| 000 | 01729 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513101833.0 | ||
| 264 | 0 | _c19961023 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a0895-7061 | ||
| 024 | 7 |
_a10.1016/0895-7061(95)00183-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLindberg, R A | |
| 245 | 0 | 0 |
_aSpontaneously hypertensive rats are resistant to the development of hypercholesterolemia. _h[electronic resource] |
| 260 |
_bAmerican journal of hypertension _cOct 1995 |
||
| 300 |
_a1001-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBlood Vessels _xdrug effects |
| 650 | 0 | 4 |
_aCholesterol, Dietary _xpharmacology |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 |
_aFluorescein-5-isothiocyanate _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHeart Rate _xdrug effects |
| 650 | 0 | 4 |
_aHypercholesterolemia _xetiology |
| 650 | 0 | 4 |
_aHypertension _xcomplications |
| 650 | 0 | 4 | _aLight |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNG-Nitroarginine Methyl Ester |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNitroprusside _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred SHR |
| 650 | 0 | 4 | _aRats, Inbred WKY |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSerum Albumin, Bovine |
| 650 | 0 | 4 | _aVasodilation |
| 700 | 1 | _aSchuschke, D A | |
| 700 | 1 | _aMiller, F N | |
| 773 | 0 |
_tAmerican journal of hypertension _gvol. 8 _gno. 10 Pt 1 _gp. 1001-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0895-7061(95)00183-2 _zAvailable from publisher's website |
| 999 |
_c8839243 _d8839243 |
||